Literature DB >> 21150180

Thrombomodulin and von Willebrand factor: relation to endothelial dysfunction and disease outcome in children with acute lymphoblastic leukemia.

Emmanouel S Hatzipantelis1, Miranda Athanassiou-Metaxa, Nikolaos Gombakis, Vaso Tzimouli, Anna Taparkou, Vasiliki Sidi-Fragandrea, Vasilia Garipidou, Theothotis Papageorgiou, Drosia Kleta, Dimitrios E Koliouskas, Fani Athanasiadou-Piperopoulou.   

Abstract

The severe endothelial dysfunction in children with acute lymphoblastic leukemia (ALL) can result from the disease itself, from treatment, or from other conditions (e.g. sepsis). The aim of this study was to determine the levels of markers of endothelial activation in children with ALL and to assess their potential prognostic value. Fifty-two children with ALL, 19 children with ALL 1-10 years after the completion of therapy, and 28 healthy children were studied. In children with ALL, there was a significant increase in thrombomodulin (TM) and von Willebrand factor (vWF) levels during the acute phase of the disease and during treatment. Children with an unfavorable outcome had higher levels of TM. In conclusion, severe endothelial dysfunction is present during the acute phase of ALL and during treatment and appears to result from the disease itself. Serum TM and vWF levels might represent additional, but not independent, prognostic markers in childhood ALL.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21150180     DOI: 10.1159/000322120

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  9 in total

1.  A human ESC model for MLL-AF4 leukemic fusion gene reveals an impaired early hematopoietic-endothelial specification.

Authors:  Clara Bueno; Rosa Montes; Gustavo J Melen; Verónica Ramos-Mejia; Pedro J Real; Verónica Ayllón; Laura Sanchez; Gertrudis Ligero; Iván Gutierrez-Aranda; Agustín F Fernández; Mario F Fraga; Inmaculada Moreno-Gimeno; Deborah Burks; María del Carmen Plaza-Calonge; Juan C Rodríguez-Manzaneque; Pablo Menendez
Journal:  Cell Res       Date:  2012-01-03       Impact factor: 25.617

2.  Vascular endothelial dysfunction after anthracyclines treatment in children with acute lymphoblastic leukemia.

Authors:  Woo Jung Jang; Duk Yong Choi; In-Sang Jeon
Journal:  Korean J Pediatr       Date:  2013-03-18

3.  Endothelial dysfunction and thromboembolism in children, adolescents, and young adults with acute lymphoblastic leukemia.

Authors:  Liv Andrés-Jensen; Kathrine Grell; Cecilie Utke Rank; Birgitte Klug Albertsen; Ruta Tuckuviene; Rikke Linnemann Nielsen; Line Stensig Lynggaard; Kirsten Brunsvig Jarvis; Petter Quist-Paulsen; Sonata Saulyte Trakymiene; Rūta Semaškevičienė; Kadri Saks; Olafur Gisli Jonsson; Thomas Leth Frandsen; Pär Ingemar Johansson; Kjeld Schmiegelow
Journal:  Leukemia       Date:  2021-08-13       Impact factor: 11.528

4.  Heparins that block VEGF-A-mediated von Willebrand factor fiber generation are potent inhibitors of hematogenous but not lymphatic metastasis.

Authors:  Lukas Goertz; Stefan Werner Schneider; Anna Desch; Frank Thomas Mayer; Julian Koett; Kai Nowak; Ioannis Karampinis; Michael K Bohlmann; Viktor Umansky; Alexander Thomas Bauer
Journal:  Oncotarget       Date:  2016-10-18

5.  Endothelial Function in Children with Acute Lymphoblastic Leukemia (ALL) May Reflect the Clinical Outcome.

Authors:  Adrian Doroszko; Ewa Niedzielska; Maciej Jakubowski; Julita Porwolik; Aleksandra Turek-Jakubowska; Ewa Szahidewicz-Krupska; Bartosz Sieczkowski; Piotr Dobrowolski; Aneta Radziwon; Robert Skomro; Arkadiusz Derkacz; Grzegorz Mazur; Alicja Chybicka; Andrzej Szuba
Journal:  Biomed Res Int       Date:  2018-11-11       Impact factor: 3.411

6.  Enhanced hemato-endothelial specification during human embryonic differentiation through developmental cooperation between AF4-MLL and MLL-AF4 fusions.

Authors:  Clara Bueno; Fernando J Calero-Nieto; Xiaonan Wang; Rafael Valdés-Mas; Francisco Gutiérrez-Agüera; Heleia Roca-Ho; Veronica Ayllon; Pedro J Real; David Arambilet; Lluis Espinosa; Raul Torres-Ruiz; Antonio Agraz-Doblas; Ignacio Varela; Jasper de Boer; Anna Bigas; Bertie Gottgens; Rolf Marschalek; Pablo Menendez
Journal:  Haematologica       Date:  2019-01-24       Impact factor: 9.941

Review 7.  The role of VWF/FVIII in thrombosis and cancer progression in multiple myeloma and other hematological malignancies.

Authors:  Claire Comerford; Siobhan Glavey; John Quinn; Jamie M O'Sullivan
Journal:  J Thromb Haemost       Date:  2022-06-23       Impact factor: 16.036

Review 8.  Endothelial Dysfunction in Childhood Cancer Survivors: A Narrative Review.

Authors:  Marco Crocco; Giuseppe d'Annunzio; Alberto La Valle; Gianluca Piccolo; Decimo Silvio Chiarenza; Carolina Bigatti; Marta Molteni; Claudia Milanaccio; Maria Luisa Garrè; Natascia Di Iorgi; Mohamad Maghnie
Journal:  Life (Basel)       Date:  2021-12-29

9.  Von Willebrand factor, ADAMTS13 and mortality in dialysis patients.

Authors:  Gurbey Ocak; Mark Roest; Marianne C Verhaar; Maarten B Rookmaaker; Peter J Blankestijn; Willem Jan W Bos; Rob Fijnheer; Nathalie C Péquériaux; Friedo W Dekker
Journal:  BMC Nephrol       Date:  2021-06-16       Impact factor: 2.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.